在非老年人中,对心交叉导管边缘到边缘修复
Alon Shechter1, Tarun Chakravarty2, Ran Kornowski3
1Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Cardiology, Rabin Medical Center, Petach Tikva, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Canadian journal of cardiology
|February 3, 2024
概括
在90岁及以上的患者中,对位管过导管端到端修复 (TEER) 是安全有效的. 这项研究发现,对于非老年人和接受TEER治疗的年轻患者来说,他们的结局是相似的.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 老年医学 老年医学
背景情况:
- 对于90岁及以上患者的跨导管端到端修复 (TEER) 有有限的数据.
- 这个人口群体正在迅速增长,需要了解TEER的可行性和这一群体的结果.
研究的目的:
- 为了评估患者的特征,程序方面和TEER在非老年人中的临床结果.
- 为了比较90岁及以上的患者和90岁以下的患者的治疗结果.
主要方法:
- 一个单一中心数据库对967个孤立的,首次TEER干预的回顾性分析.
- 103名患者 (10.7%) 是非老年人;结果包括死亡率,心力衰竭住院和持续显著的额头骨吐 (MR) 或NYHA类III/IV.
- 倾向性得分匹配分析在204名患者的子队列中进行.
主要成果:
- 非老年人更有可能是具有更高社会经济地位的白人女性,具有更高的干预风险 (年龄,CKD) 和初级MR.
- 在这两组中,技术成功率都很高 (>97%).
- 在非老年人和年轻患者之间,没有观察到死亡率,HF住院或MR持续性的显著差异.
结论:
- 与年轻患者相比,在90岁及以上的患者中,米特拉TEER同样可行,安全和有效.
- 90岁及以上的年龄与研究结果的风险增加无关.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...


